IndraLab

Statements

N-benzyloxycarbonyl-L-leucyl-L-leucyl-L-leucinal activates USP14. 1 / 1

| 1

➶

reach

"Treatment with the proteasome inhibitor MG132 reversed the protective effects of USP14 aptamers."

26041011

INDRA sources:

Colored badges next to statement headings correspond to evidence counts from knowledge sources, as shown below. Badges to the left of the | separator correspond to curated knowledge base sources, and badges to the right of it correspond to machine reading systems.

IndraLab

Statements

N-benzyloxycarbonyl-L-leucyl-L-leucyl-L-leucinal activates USP14. 1 / 1

INDRA sources:

Databases

Reading